Ken Griffin Clear Point Neuro, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 65,600 shares of CLPT stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,600
Previous 28,000
134.29%
Holding current value
$1.2 Million
Previous $313,000
222.04%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CLPT
# of Institutions
90Shares Held
7.25MCall Options Held
352KPut Options Held
37.7K-
Vanguard Group Inc Valley Forge, PA1.25MShares$22.9 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA509KShares$9.33 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA409KShares$7.49 Million1.22% of portfolio
-
Black Rock Inc. New York, NY366KShares$6.71 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$6.11 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $449M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...